Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,551 | 91 | 94.0% |
| Education | $288.34 | 4 | 6.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $1,699 | 20 | $0 (2024) |
| Allergan, Inc. | $941.30 | 34 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $421.73 | 7 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $385.97 | 7 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $325.11 | 10 | $0 (2024) |
| AbbVie Inc. | $285.81 | 3 | $0 (2023) |
| ITI, Inc. | $208.52 | 4 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $165.33 | 3 | $0 (2024) |
| Shire North American Group Inc | $140.23 | 2 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $99.99 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $751.24 | 14 | Alkermes, Inc. ($227.41) |
| 2023 | $878.00 | 14 | Alkermes, Inc. ($356.76) |
| 2022 | $830.28 | 14 | Alkermes, Inc. ($410.62) |
| 2021 | $433.07 | 6 | Alkermes, Inc. ($224.63) |
| 2020 | $376.71 | 4 | Alkermes, Inc. ($354.70) |
| 2019 | $488.23 | 16 | Allergan Inc. ($363.27) |
| 2018 | $653.18 | 18 | Allergan Inc. ($490.55) |
| 2017 | $429.04 | 9 | Sunovion Pharmaceuticals Inc. ($238.57) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $84.23 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $38.31 | General |
| Category: SCHIZOPHRENIA | ||||||
| 08/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.57 | General |
| Category: PSYCHIATRY | ||||||
| 05/09/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $89.60 | General |
| Category: CNS | ||||||
| 04/25/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $123.11 | General |
| Category: PSYCHIATRY | ||||||
| 03/22/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: PSYCHIATRY | ||||||
| 03/21/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $0.58 | General |
| Category: PSYCHIATRY | ||||||
| 03/15/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: CNS | ||||||
| 02/21/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $110.09 | General |
| Category: CNS | ||||||
| 02/16/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: BH | ||||||
| 02/08/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $127.80 | General |
| Category: Neurology | ||||||
| 01/31/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: PSYCHIATRY | ||||||
| 01/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: Neuropsychiatry | ||||||
| 12/07/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $119.86 | General |
| Category: Neuropsychiatry | ||||||
| 11/17/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $122.76 | General |
| Category: CNS | ||||||
| 11/17/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: OUD | ||||||
| 11/17/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: CNS | ||||||
| 09/19/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: NEUROLOGY | ||||||
| 08/17/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $30.37 | General |
| Category: Neurology | ||||||
| 07/21/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: PSYCHIATRY | ||||||
| 06/14/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Neurology | ||||||
| 04/28/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $99.76 | General |
| Category: CNS | ||||||
| 04/10/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Neuroscience | ||||||
| 03/17/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 47 | 128 | $11,418 | $5,687 |
| 2022 | 3 | 50 | 104 | $12,829 | $5,296 |
| 2021 | 3 | 56 | 191 | $30,800 | $10,575 |
| 2020 | 3 | 51 | 175 | $23,118 | $9,454 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 52 | $3,925 | $2,729 | 69.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 41 | $5,464 | $1,595 | 29.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 15 | 35 | $2,029 | $1,363 | 67.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 41 | $3,095 | $2,141 | 69.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 37 | $8,191 | $2,107 | 25.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 16 | 26 | $1,544 | $1,049 | 67.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 25 | 79 | $22,717 | $4,501 | 19.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 66 | $4,982 | $3,650 | 73.3% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 15 | 46 | $3,101 | $2,425 | 78.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 81 | $6,114 | $4,096 | 67.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 17 | 47 | $13,835 | $2,833 | 20.5% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 17 | 47 | $3,169 | $2,524 | 79.7% |
About Dr. Kazi Salahuddin, MD
Dr. Kazi Salahuddin, MD is a Psychiatry healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558306225.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kazi Salahuddin, MD has received a total of $4,840 in payments from pharmaceutical and medical device companies, with $751.24 received in 2024. These payments were reported across 95 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($4,551).
As a Medicare-enrolled provider, Salahuddin has provided services to 204 Medicare beneficiaries, totaling 598 services with total Medicare billing of $31,013. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Providence, RI
- Active Since 06/18/2006
- Last Updated 03/31/2009
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1558306225
Products in Payments
- VRAYLAR (Drug) $1,227
- ARISTADA (Drug) $1,054
- LYBALVI (Drug) $638.09
- LATUDA (Drug) $385.97
- CAPLYTA (Drug) $208.52
- UZEDY (Drug) $172.07
- ABILIFY MAINTENA (Drug) $167.36
- INGREZZA (Drug) $165.33
- MYDAYIS (Drug) $140.23
- AUSTEDO (Drug) $138.21
- INVEGA SUSTENNA (Drug) $99.99
- COBENFY (Drug) $84.23
- REXULTI (Drug) $80.78
- FANAPT (Drug) $38.31
- NUEDEXTA (Drug) $27.71
- ABILIFY ASIMTUFII (Drug) $25.47
- ABILIFY MYCITE (Drug) $23.79
- SUBLOCADE (Drug) $23.08
- PERSERIS (Drug) $21.06
- VIVITROL (Drug) $7.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Providence
Dr. James Greer, Md, MD
Psychiatry — Payments: $727,742
Linda Carpenter, Md, MD
Psychiatry — Payments: $43,650
Brian Ackerman
Psychiatry — Payments: $9,878
Steven Rasmussen, Md, MD
Psychiatry — Payments: $6,302
Katharine Phillips, Md, MD
Psychiatry — Payments: $4,723
Dr. Timothy Mariano, M.d., Ph.d, M.D., PH.D
Psychiatry — Payments: $4,409